Tag Archive for: life sciences
MBTAAnalysis: A look inside the MBTA
0 Comments
/
The MBTA shuttles over a million passengers a day around Greater…
Virtual Policy Briefing: Exploring the Intersection of Vocational-Technical Education and the Life Sciences Sector
Massachusetts is the nation’s leader in vocational-technical schooling and home to the most dynamic life sciences sector in America. We invite you to join us for a webinar on the nexus between the Bay State’s educational, life science, and competitive human capital needs in the 21st-century global economy.
Opinion: Drug patents aren’t a ‘necessary evil.’ They save lives.
Drug patents are one of the most important public policy innovations in all of human history, and a boon to patients awaiting cures. Inventions only come when inventors are rewarded, not punished. Patents are not a “necessary evil.”
Out-of-Pocket Pirates: Spotlight on Accumulator & Maximizer Programs
A new white paper, "Out-of-Pocket Pirates: Pharmacy Benefit Managers (PBMs) and the Confiscation of Copayment Assistance Programs," examines how the way these programs are implemented is having negative impacts on patients living with serious diseases.
What’s going on with the economy in Cambridge?
Dubbed the city of squares, Cambridge, a leading innovation center,…
Avak Kahvejian on How Immigrants Drive Innovation
This week on JobMakers, host Denzil Mohammed talks with Dr. Avak Kahvejian, an inventor, entrepreneur and CEO as well as general partner at Flagship Pioneering, a life sciences venture capital company in Cambridge, Massachusetts.
The Promise and Challenges of Rare Cancer Treatments
Dr. William Smith, Pioneer Institute's Visiting Fellow in Life Sciences, spoke about the challenges and opportunities for rare cancer treatments, in a video interview produced by Rare Cancers, a patient group based in Australia, for the November 26th CAN Forum.
Report: Rare Disease Patients Hurt by “One-Size-Fits-All” ICER Framework
This op-ed appeared in ICERWatch on June 26, 2019.
The Institute…
Putting a Price on Life: The Coming Fight Over Government Rationing of Medical Care
This article appeared on The Mackinac Center for Public Policy…
Here’s why Sarah Palin’s ‘death panels’ are now being debated in Massachusetts
This op-ed by Shira Schoenberg appeared in MassLive on April…
Issue Brief: Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology
This article by Chris Rochester appeared in The MacIver Institute…
Commentary: Proposed Drug Price Caps Would Stall Advances in Health Care
This op-ed by William Smith and Adam Crepeau appeared in the…
HHS Secretary Alex Azar doesn’t want drug access to become an equation
This op-ed by William Smith appeared in the Washington Examiner…
The U.S. shouldn’t use the ‘QALY’ in drug cost-effectiveness reviews
This op-ed by William Smith appeared in STAT News on February…
Baker’s Orwellian drug pricing policy
This op-ed by William Smith appeared in Commonwealth Magazine…
New Life Science Industry report: Mass. gained only 55 life science jobs between 2010 and 2012
Last week, Pioneer Institute issued a report calling for Massachusetts…
Study: Tax Credits Would Help MA Stem Loss of R&D Market Share
$1 billion life sciences initiative has created just 571 jobs,…